Abstract:Objective To investigate the effect of BCG-PSN by different methods of intervention on airway inflammation and airway reactivity in asthmatic mouse model. Methods Balb/c mice were sensitized by ovalbumin to establish the asthmatic mouse model and divided into normal group, asthma group and BCG-PSN intervention group.For BCG-PSN intervention group, the dose of BCG-PSN was 20 μg/60 μl, all of which were intervened after the final excitation, and according to the intervention methods, the intervention group was subdivided into the intramuscular injection group ( im) and intranasal administration after anesthesia group (in). Airway responsiveness was measured by Buxco company's mice overall volume scanning method in 2 d, 14 d respectively after final excitation, which was demonstrated by enhanced breathing intermittence (Enhanced Pause, Penh) under different concentrations of methacholine stimulation. Airway reactivity was evaluated by PC100 ( Mch excitation concentration when the increased airway reactivity is 2 times of physiological saline ( NS) ) and Penh/NS% comprehensively. The bronchoalveolar lavage fluid was collected and the ratio of eosinophils was counted in the smears stained with haematoxylin and eosin, and with pathological examination of lung tissue. Results BCG-PSN (im) group PC100 was (9.48±3.06) mg/ml in early stages, compared with asthma group (4.79±1.51)mg/ml, P＜0.05, in the later stages PC100 was (4.96±1.88) mg/ml, (5.55± 3.11) mg/ml for asthma group, there was no statistically significant differences in these two groups, for BCG-PSN(in) group, PC100 is (12.39±4.89)mg/ml,(9.19±2.35)mg/ml in early and later stages respectively, compared with the asthma group, had statistical significance (P＜0.05), and in later stages, BCG-PSN(in) group was significantly higher than BCG-PSN(im) group. For the Eos% in BALF, asthma group was (40.73± 6.01)%, and BCG-PSN(im) group was (35.65±4.27)%, there was no significant difference between these two groups, BCG-PSN(in) group was (30.98±5.45)%, which is significantly lower than the asthma group (P＜0.05). Conclusion BCG-PSN has a therapeutic effect on the asthmatic mice. The effects of BCG-PSN by intranasal administration after anesthesia are equivalent to or even superior to the effects by intramuscular administration, BCG-PSN by intratracheal administration is expected to become a new way for prevention and therapy on asthma.

A Comparative Study on Immune Modulatory Effects of Bacilli Calmette-Guérin Polysaccharides Nucleic Acid in Asthma and Chronic Obstructive Pulmonary Disease

A comparative study on immune modulatory effects of bacilli Calmette-Guérin polysaccharides nucleic acid in asthma and chronic obstructive pulmonary disease

Expression of IFN-γ,IL-4 and IL-17A in asthmatic mice vaccinated with BCG and HepB in neonatal period

Effect of BCG Polysaccharides Nucleic Acid on Immunologic Function in Patients with Chronic Obstructive Pulmonary Disease

Effects of bacillus calmette-guerin polysaccharide nucleotide on CD4+ CD25+ Treg in lymph of asthmatic mouse model

Effects of bacillus calmette-guerin polysaccharide nucleotide by different ways of intervention on airway inflammation and airway hyperresponsiveness in asthmatic mouse model

Phosphodiesterases Inhibition by Bacilli Calmette-Guérin Contributes to Decrease Asthma in Allergic Rats

Effect of BCG-PSN Acupoint Injection on IgE Content and Asthma Control Test Score of Bronchial Asthma

Effects of Bacillus Calmette-Guerin on Th1/Th2 Balance of Peripheral Blood Mononuclear Cells in Patients with Atopic Asthma

Effect of Bacillus Calmette-guerin Polysaccharide Nucleic Acid on the Inflammatory Factors and Immune Functions of Patients with Chronic Obstructive Pulmonary Disease

Clinical observation of pulmicort combined with BCG-PSN in asthma.

Altered Frequency of NK Cells and Treg Cells by <i>Astragalus</i> Polysaccharide Combined with Budesonide in Asthma Model Mice

The Expression of Dendritic Cells and Effects of Bacillus Calmette-Guérin in Asthma Mice Model

Effect of BCG DNA on IFN- Γand IL-4 Secreted by Peripheral Blood Mononuclear Cells in Asthma Patients

The effect of bacillus Calmette-guerin vaccination and PPD on CD4~+ CD25~+ regulatory T cells and the lung pathology in a murine model of asthma

Effect of Bacillus Calmette-Guerin Treatment on Airway Inflammation and T Regulatory Cells in Mice with Asthma

Bronchial Asthma Treated with Acupoint Injection of BCG-PSN in Summer:A Randomized Controlled Trial

Effects of bacillus Calmette -Guerin vaccinated at ovalbumin sensitization on airway inflammation in a mouse model of asthma

Study about effects of BCG treatment on expression of stem cell factor in asthmatic mice

Effects of Bacillus Calmette-Guerin on airway inflammation, T helper cell differentiation and serum OVA-specific IgE levels in a mouse model of asthma

[An Experimental Study of the Effect of Bacille Calmette-Guerin Vaccine on the Production of a Rat Asthmatic Model and Its Relation with Gamma Delta T Cells].